ψ 
DNA Topoisomerases, Type II 
DNA TOPOISOMERASES that catalyze ATP-dependent breakage of both strands of DNA, passage of the unbroken strands through the breaks, and rejoining of the broken strands. These enzymes bring about relaxation of the supercoiled DNA and resolution of a knotted circular DNA duplex.  GEN or unspecified; prefer specifics    Other names DNA Topoisomerase II; DNA Topoisomerase (ATP-Hydrolysing); Type II DNA Topoisomerase; Topoisomerase II; DNA Type 2 Topoisomerase; DNA Topoisomerase II; DNA Topoisomerase (ATP-Hydrolysing)
 
SubstanceCAS Registry & nameCategoriesSourceDrugs*
baicalein  491-67-8 5,6,7-trihydroxyflavone  *Flavanones DNA Topoisomerases, Type II/antagonists & inhibitors Dinoprostone/antagonists & inhibitors. 
Pharma Action Antioxidants ; Enzyme Inhibitors ; Prostaglandin Antagonists
Jap J Pharmacol 25:763;1975
microcin  1403-96-9   *Bacteriocins Anti-Bacterial Agents DNA Topoisomerases, Type II/antagonists & inhibitors.  Biochem Biophys Res Commun 88(1):297;1979
coumermycins  4434-05-3   Aminocoumarins DNA Topoisomerases, Type II/antagonists & inhibitors. 
Pharma Action Antibiotics, Antineoplastic ; Enzyme Inhibitors
Biochemistry 15(17):3769-78;1976; J Mol Biol 120:145;1978; J Mol Biol 1979;131(3):637; MGG 1979;176(1):25; MGG 1979;176(2):171; MGG 1979;177(1):169; MGG 1980;177(2):301; Mol Biol (Mosk) 1979;13(6):1341; Proc Nat Acad Sci USA 73(12):4474;1976; Proc Nat Acad Sci USA 75(10):4838;1978; Proc Nat Acad Sci USA 75(9):4125;1978
DNA topoisomerase II beta  EC 5.99.1.3   *DNA Topoisomerases, Type II *DNA-Binding Proteins.  Neurosci Res 1994 Feb;19(1):51-7
ICRF 193  21416-68-2   *Piperazines DNA Topoisomerases, Type II/antagonists & inhibitors. 
Pharma Action Antineoplastic Agents ; Enzyme Inhibitors
Cancer Res 1991;51(18):4903
marbofloxacin  115550-35-1   *Quinolones *Fluoroquinolones DNA Topoisomerases, Type II/antagonists & inhibitors. 
Pharma Action Enzyme Inhibitors
Zentralbl Veterinarmed (A) 1993 Feb;40(1):73-9
NSC 336628  97534-21-9 5-Pyrimidinecarboxamide, hexahydro-4,6-dioxo-N-phenyl-2-thioxo  *Thiobarbiturates DNA Topoisomerases, Type II/antagonists & inhibitors. 
Pharma Action Antineoplastic Agents ; Enzyme Inhibitors
Biochem Pharmacol 1985;34(11):2047
NSC 601316  89459-25-6 4-Acridinecarboxamide, N-(2-(dimethylamino)ethyl)  *Acridines DNA Topoisomerases, Type II/antagonists & inhibitors. 
Pharma Action Antineoplastic Agents ; Enzyme Inhibitors ; Intercalating Agents
Eur J Cancer Clin Oncol 1988;24(11):1783
cryptolepine  480-26-2 5H-Quindoline, 5-methyl  *Alkaloids *Indoles *Quinolines DNA Topoisomerases, Type II/antagonists & inhibitors Asclepiadaceae. 
Pharma Action Adrenergic alpha-Antagonists ; Antimalarials ; Antineoplastic Agents, Phytogenic ; Enzyme Inhibitors ; Hypoglycemic Agents ; Intercalating Agents ; Vasodilator Agents
J Pharm Sci 68(12):1510;1979
sobuzoxane  98631-95-9   *Piperazines DNA Topoisomerases, Type II/antagonists & inhibitors. 
Pharma Action Antineoplastic Agents
Chung Kuo Yao Li Hsueh Pao 1988;9(4):369
TAS 103  0   *Aminoquinolines *Indenes DNA Topoisomerases, Type II/antagonists & inhibitors DNA Topoisomerases, Type I/antagonists & inhibitors.  J Chromatogr B Biomed Appl 1997 Mar 28;691(1):179-85
bakuchiol  10309-37-2 4-(3-ethenyl-3,7-dimethyl-1,6-octadienyl)phenol  *Phenols DNA Topoisomerases, Type II/antagonists & inhibitors DNA-Directed DNA Polymerase/antagonists & inhibitors.  Arzneim Forsch(Drug Res)26(4):486;1976
serpentine (alkaloid)  18786-24-8 (19 alpha)-3,4,5,6,16,17-hexadehydro-16-(methoxycarbonyl)-19-methyloxayohimbanium  *Secologanin Tryptamine Alkaloids DNA Topoisomerases, Type II/antagonists & inhibitors.  Exp Cell Biol 1982;50(2):79; J Chromatogr 100(1):231;1974
intoplicine  125974-72-3 7H-Benzo(e)pyrido(4,3-b)indol-3-ol, 11-((3-(dimethylamino)propyl)amino)-8-methyl  *Indoles *Pyridines DNA Topoisomerases, Type II/antagonists & inhibitors DNA Topoisomerases, Type I/antagonists & inhibitors.  J Chromatogr 1993 May 5;614(2):299-306
pixantrone  144510-96-3   *Isoquinolines DNA Topoisomerases, Type II/antagonists & inhibitors.  J Med Chem 1994 Mar 18;37(6):828-37
psammaplin A  110659-91-1   *Disulfides Tyrosine/*analogs & derivatives DNA Topoisomerases, Type II/antagonists & inhibitors.  Arch Pharm Res 1999 Feb;22(1):25-9; J Nat Prod 1995 Nov;58(11):1722-6
F 11782  0   DNA Topoisomerases, Type II/antagonists & inhibitors DNA Topoisomerases, Type I/antagonists & inhibitors *Naphthalenes *Pyrans.  Biochem Pharmacol 2000 Apr 1;59(7):807-19
phenoxodiol  0 2H-1-benzopyran-7-0,1,3-(4-hydroxyphenyl)  DNA Topoisomerases, Type II/antagonists & inhibitors *Isoflavones.  Anticancer Res 2002 Sep-Oct;22(5):2581-5
cyclothialidine  147214-63-9 L-Alanine, N-(S-((2-carboxy-4,6-dihydroxy-3-methylphenyl)methyl)-N-(N-(cis-3-hydroxy-1-L-seryl-L-prolyl)-L-seryl)-L-cysteinyl)-, kappa-lactone  *Peptides, Cyclic DNA Topoisomerases, Type II/antagonists & inhibitors.  Antimicrob Agents Chemother 1993 Dec;37(12):2656-61
3'-deamino-3'-hydroxydoxorubicin  73113-90-3 5,12-Naphthacenedione, 10-((2,6-dideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)  Epirubicin/*analogs & derivatives DNA Topoisomerases, Type II/antagonists & inhibitors.  J Antibiot (Tokyo) 1984;37(8):853
azatoxin  129564-92-7   *Indoles DNA Topoisomerases, Type II/antagonists & inhibitors.  Cancer Res 1992 Aug 15;52(16):4478-83
SbmC protein, E coli  0   *Repressor Proteins *Escherichia coli Proteins DNA Topoisomerases, Type II.  J Biol Chem 1998 Jan 23;273(4):1933-8
neocryptolepine  0   DNA Topoisomerases, Type II/antagonists & inhibitors Asclepiadaceae *Alkaloids *Quinolines.  Anticancer Drug Des 2000 Jun;15(3):191-201
NSC 659687  0   *Carbazoles *Pyridines DNA Topoisomerases, Type II/antagonists & inhibitors.  J Natl Cancer Inst 1999 Feb 3;91(3):236-44
2,3-benzo-1,4-dimethyl-alpha-iso-carboline  114414-79-8   *Carbolines DNA Topoisomerases, Type II/antagonists & inhibitors.  Arch Immunol Ther Exp (Warsz) 1987;35(2):143
PD 138312  107334-06-5   *Naphthyridines *Fluoroquinolones DNA Topoisomerases, Type II/antagonists & inhibitors.  Antimicrob Agents Chemother 1993 Dec;37(12):2563-70
A 62176  148201-53-0   *Oxazines *Quinolones DNA Topoisomerases, Type II/antagonists & inhibitors.  J Med Chem 1995 Feb 3;38(3):408-24
BN 80927  0   Camptothecin/*analogs & derivatives DNA Topoisomerases, Type II/antagonists & inhibitors DNA Topoisomerases, Type I/antagonists & inhibitors.  Bioorg Med Chem Lett 1999 Sep 6;9(17):2599-602
alpha-lapachone  0   DNA Topoisomerases, Type II/antagonists & inhibitors *Naphthoquinones.  Biochem Pharmacol. 2000 Nov 1;60(9):1367-79
4-methoxybenzo(a)phenazine-11-carboxylic acid (2-(dimethylamino)-1-methylethyl)amide  0   DNA Topoisomerases, Type II/antagonists & inhibitors DNA Topoisomerases, Type I/antagonists & inhibitors *Phenazines.  J Med Chem 2002 Jan 31;45(3):721-39
BE 13793C  133805-03-5   *Carbazoles *Indoles DNA Topoisomerases, Type II/antagonists & inhibitors DNA Topoisomerases, Type I/antagonists & inhibitors.  J Antibiot (Tokyo) 1991;44(7):723
GR 122222X  161161-54-2   *Peptides, Cyclic DNA Topoisomerases, Type II/antagonists & inhibitors.  J Mol Biol 1994 Aug 5;241(1):128-30
isoaurostatin  0   DNA Topoisomerases, Type II/antagonists & inhibitors *Benzofurans.  J Nat Prod 2001 Feb;64(2):204-7
BE 10988  135261-89-1 4-Thiazolecarboxamide, 2-(5-amino-4,7-dihydro-1-methyl-4,7-dioxo-1H-indol-3-yl)  *Thiazoles DNA Topoisomerases, Type II/antagonists & inhibitors.  J Antibiot (Tokyo) 1991;44(5):486
BE 22179  147816-33-9 Alanine, N-((3-hydroxy-2-quinolinyl)carbonyl)cysteinylglycyl-N-methylcysteinyl-2,3-didehydro-N-methylthio-, bimol. (4-1'),(4'-1)-(thio lactone), cyclic (3-3')-disulfide  *Peptides DNA Topoisomerases, Type II/antagonists & inhibitors.  J Antibiot (Tokyo) 1994 Feb;47(2):129-35
PD 161148  0   Ciprofloxacin/*analogs & derivatives DNA Topoisomerases, Type II/antagonists & inhibitors.  Proc Natl Acad Sci U S A 1997 Dec 9;94(25):13991-6
Ro 47-3359  155144-64-2   *Benzimidazoles *Pyrimidines DNA Topoisomerases, Type II/antagonists & inhibitors.  Antimicrob Agents Chemother 1993 Dec;37(12):2599-605
makaluvamine N  0   *Pyrroles *Quinolones DNA Topoisomerases, Type II/antagonists & inhibitors.  J Nat Prod 1997 Apr;60(4):408-10
PD 160793  0   Ciprofloxacin/*analogs & derivatives DNA Topoisomerases, Type II/antagonists & inhibitors.  Proc Natl Acad Sci U S A 1997 Dec 9;94(25):13991-6
Ruthenium Ben  0   *Organometallic Compounds Dimethyl Sulfoxide DNA Topoisomerases, Type II/antagonists & inhibitors.  Biochemistry 1999 Apr 6;38(14):4382-8
2,3-dihydroindolizino(7,6,5-kl)acridinium chloride  0   *Acridines *Indoles DNA Topoisomerases, Type II/antagonists & inhibitors.  Biochemistry 1999 May 25;38(21):6723-31
4-methyl-7-(tetradecanoyl)-2H-1-benzopyran-2-one  0   DNA Topoisomerases, Type II/antagonists & inhibitors *Coumarins.  Parasitol Res 2004 Feb;92(3):177-82
carbobenzoxycoumarin  93729-75-0   *Coumarins DNA Topoisomerases, Type II/antagonists & inhibitors.  J Antibiot (Tokyo) 1988;41(3):373
chlorobiocic acid  114515-20-7 Benzamide, N-(8-chloro-4,7-dihydroxy-2-oxo-2H-1-benzopyran-3-yl)-4-hydroxy-3-(3-methyl-2-butenyl)  *Coumarins DNA Topoisomerases, Type II/antagonists & inhibitors.  J Antibiot (Tokyo) 1988;41(3):373
9'-fluoro-10'-(4-methyl-1-piperazinyl)-7'-oxospiro(cyclopropane-1,3'(2'H)-(7H)pyrido(1,2,3-de)(1,4)benzoxazine)-6'-carboxylic acid  113211-53-3   *Oxazines DNA Topoisomerases, Type II/antagonists & inhibitors.  J Med Chem 1988;31(9):1694
2-(4-methoxyphenyl)-5-((4-methylpiperazin-1-yl)-3H-imidazo(4,5-b)pyridin-2-yl)-3H-imidazo(4,5-b)pyridine  142764-75-8   Bisbenzimide/*analogs & derivatives DNA Topoisomerases, Type II/antagonists & inhibitors Ligands.  Chem Res Toxicol 1992 Sep-Oct;5(5):597-607
bastadin 14  146345-73-5 2,18-Dioxa-10,27-diazapentacyclo(28.2.2.214,17.13,7.119,23)octatriaconta-3,5,7(38),14,16,19,21,23(35),28,30,32,33,36-tridecaene-11,12,25,26-tetrone, 5,16,21,32,33-pentabromo-4,20-dihydroxy-, 12,15-bis(O-methyloxime), (E,E,?)  *Phenyl Ethers DNA Topoisomerases, Type II/antagonists & inhibitors Tetrahydrofolate Dehydrogenase/antagonists & inhibitors.  J Nat Prod 1993 Jan;56(1):153-7
5,8-bis(2-aminoethylamino)-1-azaanthracene-9,10-dione  150629-26-8   *Anthraquinones *Quinolones DNA Topoisomerases, Type II/antagonists & inhibitors.  Biochem Pharmacol 1993 Jul 20;46(2):265-71
1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-(2,6-dimethyl-4-pyridinyl)-4-oxo-3-quinolinecarboxyic acid  123942-05-2   *Quinolones *Fluoroquinolones DNA Topoisomerases, Type II/antagonists & inhibitors.  J Med Chem 1993 Sep 17;36(19):2801-9
N-(2-(dimethylamino)ethyl)-2-(4-pyridyl)quinoline-8-carboxamide  0   *Quinolines DNA Topoisomerases, Type II/antagonists & inhibitors.  Anticancer Drug Des 1994 Feb;9(1):9-24
bis(helenalinyl)glutarate  0   *Lactones *Sesquiterpenes DNA Topoisomerases, Type II/antagonists & inhibitors.  Bioorg Med Chem 1994 Feb;2(2):137-45
bis(isoalantodiol-B)glutarate  0   *Lactones *Sesquiterpenes DNA Topoisomerases, Type II/antagonists & inhibitors.  Bioorg Med Chem 1994 Feb;2(2):137-45
8-desaminobatracylin  35970-06-0   *Indoles *Quinazolines DNA Topoisomerases, Type II/antagonists & inhibitors.  J Med Chem 1994 Sep 30;37(20):3434-9
8-azabatracylin  0   *Pyridones *Pyrimidines DNA Topoisomerases, Type II/antagonists & inhibitors.  J Med Chem 1994 Sep 30;37(20):3434-9
A 85226  0   *Oxazines *Quinolones DNA Topoisomerases, Type II/antagonists & inhibitors.  J Med Chem 1995 Feb 3;38(3):408-24
CJ 12371  0   *Naphthalenes DNA Topoisomerases, Type II/antagonists & inhibitors.  J Antibiot (Tokyo) 1995 Feb;48(2):134-42
CJ 12372  0   *Naphthalenes DNA Topoisomerases, Type II/antagonists & inhibitors.  J Antibiot (Tokyo) 1995 Feb;48(2):134-42
NU-ICRF 500  0   *Anthraquinones Serine/*analogs & derivatives DNA Topoisomerases, Type II/antagonists & inhibitors.  Mutat Res 1995 Aug;344(1-2):55-62
FD 501  0   Ciprofloxacin/*analogs & derivatives DNA Topoisomerases, Type II/antagonists & inhibitors.  Jpn J Antibiot 1996 Mar;49(3):264-72
N-(2-(dimethylamino)ethyl)-5-methyl-4-acridinecarboxamide  106626-72-6   *Acridines DNA Topoisomerases, Type II/antagonists & inhibitors.  J Med Chem 1997 Jun 6;40(12):1919-29
more...